Literature DB >> 7864652

Recombinant expression and evaluation of the lipoyl domains of the dihydrolipoyl acetyltransferase component of the human pyruvate dehydrogenase complex.

S Liu1, J C Baker, P C Andrews, T E Roche.   

Abstract

The subunits of the dihydrolipoyl acetyltransferase (E2) component of mammalian pyruvate dehydrogenase complex (PDC) associate to form a large inner core with a protruding structure composed of three globular domains connected by mobile linker regions. This exterior region of E2 includes two lipoyl domains which engage not only in the intermediate reactions of the complex but also have integral roles in the kinase-phosphatase regulatory interconversion of the pyruvate dehydrogenase (E1) component. To facilitate understanding of these roles, lipoyl domain constructs of the E2 component of human PDC were expressed as glutathione S-transferase (GST)-linked fusion proteins from plasmid inserts prepared by polymerase chain reaction procedures. The NH2-terminal lipoyl domain, E2L1, and the interior lipoyl domain, E2L2, are connected by a 30-amino-acid hinge region, H1. Constructs designed and expressed were E2L1(1-98), E2L1.H1(1-128), E2L2(120-233), E2H1.L2(98-233), and E2L1.H1.L2(1-233), where numbers in parentheses give the amino acid sequence for the portions of the E2 component incorporated into a construct. The domains were expressed in Escherichia coli with and without lipoate supplementation. GST constructs were purified to homogeneity by affinity chromatography and selectively released by thrombin treatment. Sequencing of insert DNAs and NH2-terminal sequencing confirmed that domains were produced as designed. Measurement of masses by electrospray mass spectrometry indicated that constructs with lipoylated, nonlipoylated, and octanoylated forms were produced when expression was with E. coli grown without lipoate supplementation and that fully lipoylated forms were produced upon lipoate supplementation. The lipoylation status was confirmed, following delipoylation with Enterococcus faecalis lipoamidase, by the expected decrease in mass and by the observation in native gel electrophoresis of a shift to a slower mobility (possibly less compact) form. Constructs were used in E1-catalyzed reductive-acetylation reaction in proportion to their degree of lipoylation and were effective substrates in a NADH-dependent dihydrolipoyl dehydrogenase reduction reaction. Thus, we have produced lipoyl domain constructs that can be employed in sorting the specific roles of E2L1 and E2L2 in facilitating catalytic and regulatory processes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7864652     DOI: 10.1006/abbi.1995.1124

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  5 in total

1.  Structural insight into interactions between dihydrolipoamide dehydrogenase (E3) and E3 binding protein of human pyruvate dehydrogenase complex.

Authors:  Chad A Brautigam; R Max Wynn; Jacinta L Chuang; Mischa Machius; Diana R Tomchick; David T Chuang
Journal:  Structure       Date:  2006-01-26       Impact factor: 5.006

2.  A complex lipoate utilization pathway in Listeria monocytogenes.

Authors:  Quin H Christensen; Jon A Hagar; Mary X D O'Riordan; John E Cronan
Journal:  J Biol Chem       Date:  2011-07-18       Impact factor: 5.157

3.  Pipecolic acid induces oxidative stress in vitro in cerebral cortex of young rats and the protective role of lipoic acid.

Authors:  Giovana Reche Dalazen; Melaine Terra; Carlos Eduardo Diaz Jacques; Juliana G Coelho; Raylane Freitas; Priscila Nicolao Mazzola; Carlos Severo Dutra-Filho
Journal:  Metab Brain Dis       Date:  2013-12-12       Impact factor: 3.584

4.  Crystal structure of the catalytic subunit of bovine pyruvate dehydrogenase phosphatase.

Authors:  Youzhong Guo; Weihua Qiu; Thomas E Roche; Marvin L Hackert
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2020-07-01       Impact factor: 1.056

5.  Recognition of the inner lipoyl-bearing domain of dihydrolipoyl transacetylase and of the blood glucose-lowering compound AZD7545 by pyruvate dehydrogenase kinase 2.

Authors:  Alina Tuganova; Alla Klyuyeva; Kirill M Popov
Journal:  Biochemistry       Date:  2007-06-30       Impact factor: 3.162

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.